First Eagle Investment Management LLC Buys 278,632 Shares of Haleon PLC Sponsored ADR $HLN

First Eagle Investment Management LLC raised its stake in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 9.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,335,583 shares of the company’s stock after purchasing an additional 278,632 shares during the period. First Eagle Investment Management LLC’s holdings in Haleon were worth $33,723,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. National Bank of Canada FI boosted its holdings in shares of Haleon by 6.7% during the 3rd quarter. National Bank of Canada FI now owns 17,385 shares of the company’s stock valued at $156,000 after purchasing an additional 1,099 shares during the last quarter. Oppenheimer & Co. Inc. boosted its holdings in shares of Haleon by 4.7% during the 4th quarter. Oppenheimer & Co. Inc. now owns 24,744 shares of the company’s stock valued at $250,000 after purchasing an additional 1,100 shares during the last quarter. Cary Street Partners Financial LLC boosted its holdings in shares of Haleon by 20.1% during the 2nd quarter. Cary Street Partners Financial LLC now owns 6,646 shares of the company’s stock valued at $69,000 after purchasing an additional 1,113 shares during the last quarter. Advisory Services Network LLC boosted its holdings in shares of Haleon by 7.1% during the 3rd quarter. Advisory Services Network LLC now owns 17,431 shares of the company’s stock valued at $156,000 after purchasing an additional 1,155 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its holdings in shares of Haleon by 33.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock valued at $50,000 after purchasing an additional 1,203 shares during the last quarter. Institutional investors own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

HLN has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Haleon in a report on Thursday, April 30th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Haleon in a report on Tuesday, January 20th. HSBC raised shares of Haleon from a “hold” rating to a “strong-buy” rating in a report on Wednesday, January 21st. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a research report on Thursday, January 22nd. Finally, Argus raised Haleon to a “strong-buy” rating in a research report on Tuesday, March 17th. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $13.40.

Haleon Stock Down 1.5%

Shares of NYSE HLN opened at $8.98 on Tuesday. The company has a market cap of $39.93 billion, a P/E ratio of 23.01, a PEG ratio of 2.07 and a beta of 0.15. The firm has a 50-day simple moving average of $9.88 and a two-hundred day simple moving average of $9.98. Haleon PLC Sponsored ADR has a 1 year low of $8.71 and a 1 year high of $11.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.92 and a quick ratio of 0.71.

Haleon (NYSE:HLN) last released its earnings results on Saturday, February 14th. The company reported $6.32 EPS for the quarter. The business had revenue of $3.65 billion for the quarter. Research analysts anticipate that Haleon PLC Sponsored ADR will post 0.56 earnings per share for the current year.

Haleon Dividend Announcement

The firm also recently announced a dividend, which will be paid on Thursday, May 14th. Stockholders of record on Friday, April 10th will be paid a dividend of $0.1307 per share. The ex-dividend date of this dividend is Friday, April 10th. This represents a dividend yield of 266.0%. Haleon’s dividend payout ratio is currently 61.54%.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over?the?counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self?care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.